{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T06:31:38Z","timestamp":1790231498775,"version":"4.1.0"},"reference-count":127,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,3,1]],"date-time":"2018-03-01T00:00:00Z","timestamp":1519862400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,2,20]],"date-time":"2018-02-20T00:00:00Z","timestamp":1519084800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Virus Research"],"published-print":{"date-parts":[[2018,3]]},"DOI":"10.1016\/j.virusres.2018.02.016","type":"journal-article","created":{"date-parts":[[2018,3,2]],"date-time":"2018-03-02T13:39:02Z","timestamp":1519997942000},"page":"53-62","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":154,"special_numbering":"C","title":["Critical challenges and emerging opportunities in hepatitis C virus research in an era of potent antiviral therapy: Considerations for scientists and funding agencies"],"prefix":"10.1016","volume":"248","author":[{"given":"Ralf","family":"Bartenschlager","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas F.","family":"Baumert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jens","family":"Bukh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Houghton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stanley M.","family":"Lemon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brett D.","family":"Lindenbach","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Volker","family":"Lohmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1977-6792","authenticated-orcid":false,"given":"Darius","family":"Moradpour","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"Pietschmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charles M.","family":"Rice","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert","family":"Thimme","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takaji","family":"Wakita","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.virusres.2018.02.016_bib0005","doi-asserted-by":"crossref","first-page":"258","DOI":"10.4161\/rna.8.2.15011","article-title":"Hepatitis C virus and host cell lipids: an intimate connection","volume":"8","author":"Alvisi","year":"2011","journal-title":"RNA Biol."},{"key":"10.1016\/j.virusres.2018.02.016_bib0010","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1038\/ng.3835","article-title":"Genome-to-genome analysis highlights the effect of the human innate and adaptive immune systems on the hepatitis C virus","volume":"49","author":"Ansari","year":"2017","journal-title":"Nat. Genet."},{"key":"10.1016\/j.virusres.2018.02.016_bib0015","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1126\/science.1259210","article-title":"Viral replication. Structural basis for RNA replication by the hepatitis C virus polymerase","volume":"347","author":"Appleby","year":"2015","journal-title":"Science"},{"key":"10.1016\/j.virusres.2018.02.016_bib0020","doi-asserted-by":"crossref","first-page":"3029","DOI":"10.1021\/acs.biochem.7b00212","article-title":"Overall structural model of NS5A protein from hepatitis C virus and modulation by mutations confering resistance of virus replication to cyclosporin a","volume":"56","author":"Badillo","year":"2017","journal-title":"Biochemistry"},{"key":"10.1016\/j.virusres.2018.02.016_bib0025","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1016\/j.antiviral.2014.02.013","article-title":"The past, present and future of neutralizing antibodies for hepatitis C virus","volume":"105","author":"Ball","year":"2014","journal-title":"Antiviral Res."},{"key":"10.1016\/j.virusres.2018.02.016_bib0030","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/j.coviro.2016.09.010","article-title":"Chronic hepatitis C virus infection and pathogenesis of hepatocellular carcinoma","volume":"20","author":"Bandiera","year":"2016","journal-title":"Curr. Opin. Virol."},{"key":"10.1016\/j.virusres.2018.02.016_bib0035","doi-asserted-by":"crossref","first-page":"5751","DOI":"10.1128\/JVI.02200-09","article-title":"Hepatitis C virus hypervariable region 1 modulates receptor interactions, conceals the CD81 binding site, and protects conserved neutralizing epitopes","volume":"84","author":"Bankwitz","year":"2010","journal-title":"J. Virol."},{"key":"10.1016\/j.virusres.2018.02.016_bib0040","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1016\/j.jhep.2017.04.010","article-title":"Maturation of secreted HCV particles by incorporation of secreted ApoE protects from antibodies by enhancing infectivity","volume":"67","author":"Bankwitz","year":"2017","journal-title":"J. Hepatol."},{"key":"10.1016\/j.virusres.2018.02.016_bib0045","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.tim.2010.11.005","article-title":"Assembly of infectious hepatitis C virus particles","volume":"19","author":"Bartenschlager","year":"2011","journal-title":"Trends Microbiol."},{"key":"10.1016\/j.virusres.2018.02.016_bib0050","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1038\/nrmicro3046","article-title":"The molecular and structural basis of advanced antiviral therapy for hepatitis C virus infection","volume":"11","author":"Bartenschlager","year":"2013","journal-title":"Nat. Rev. Microbiol."},{"key":"10.1016\/j.virusres.2018.02.016_bib0055","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1186\/s12916-017-0815-7","article-title":"Hepatitis C-related hepatocellular carcinoma in the era of new generation antivirals","volume":"15","author":"Baumert","year":"2017","journal-title":"BMC Med."},{"key":"10.1016\/j.virusres.2018.02.016_bib0060","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1002\/hep.22951","article-title":"Hepatitis B and C virus coinfection: a novel model system reveals the absence of direct viral interference","volume":"50","author":"Bellecave","year":"2009","journal-title":"Hepatology"},{"key":"10.1016\/j.virusres.2018.02.016_bib0065","doi-asserted-by":"crossref","first-page":"8870","DOI":"10.1128\/JVI.00059-11","article-title":"Hepatitis C virus stimulates the phosphatidylinositol 4-kinase III alpha-dependent phosphatidylinositol 4-phosphate production that is essential for its replication","volume":"85","author":"Berger","year":"2011","journal-title":"J. Virol."},{"key":"10.1016\/j.virusres.2018.02.016_bib0070","doi-asserted-by":"crossref","first-page":"1094","DOI":"10.1053\/j.gastro.2014.07.019","article-title":"Daclatasvir-like inhibitors of NS5A block early biogenesis of hepatitis C virus-induced membranous replication factories, independent of RNA replication","volume":"147","author":"Berger","year":"2014","journal-title":"Gastroenterology"},{"key":"10.1016\/j.virusres.2018.02.016_bib0075","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1126\/science.aal1962","article-title":"Mouse models of acute and chronic hepacivirus infection","volume":"357","author":"Billerbeck","year":"2017","journal-title":"Science"},{"key":"10.1016\/j.virusres.2018.02.016_bib0080","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1016\/j.jhep.2016.04.013","article-title":"First-in-human application of the novel hepatitis B and hepatitis D virus entry inhibitor myrcludex B","volume":"65","author":"Blank","year":"2016","journal-title":"J. Hepatol."},{"key":"10.1016\/j.virusres.2018.02.016_bib0085","doi-asserted-by":"crossref","first-page":"628","DOI":"10.3389\/fimmu.2016.00628","article-title":"Type III interferons in hepatitis C virus infection","volume":"7","author":"Boisvert","year":"2016","journal-title":"Front. Immunol."},{"key":"10.1016\/j.virusres.2018.02.016_bib0090","doi-asserted-by":"crossref","first-page":"2134","DOI":"10.1056\/NEJMoa1613512","article-title":"Sofosbuvir, velpatasvir, and voxilaprevir for previously treated HCV infection","volume":"376","author":"Bourliere","year":"2017","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.virusres.2018.02.016_bib0095","doi-asserted-by":"crossref","first-page":"946","DOI":"10.1038\/nature04079","article-title":"Adaptive immune responses in acute and chronic hepatitis C virus infection","volume":"436","author":"Bowen","year":"2005","journal-title":"Nature"},{"key":"10.1016\/j.virusres.2018.02.016_bib0100","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1002\/jmv.1890110304","article-title":"Non-A, non-B hepatitis in chimpanzees: interference with acute hepatitis A virus and chronic hepatitis B virus infections","volume":"11","author":"Bradley","year":"1983","journal-title":"J. Med. Virol."},{"issue":"1","key":"10.1016\/j.virusres.2018.02.016_bib0105","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1111\/jvh.12247","article-title":"Historical epidemiology of hepatitis C virus (HCV) in selected countries","volume":"21","author":"Bruggmann","year":"2014","journal-title":"J. Viral Hepat."},{"key":"10.1016\/j.virusres.2018.02.016_bib0110","doi-asserted-by":"crossref","first-page":"8183","DOI":"10.1128\/JVI.00142-08","article-title":"Previously infected chimpanzees are not consistently protected against reinfection or persistent infection after reexposure to the identical hepatitis C virus strain","volume":"82","author":"Bukh","year":"2008","journal-title":"J. Virol."},{"key":"10.1016\/j.virusres.2018.02.016_bib0115","doi-asserted-by":"crossref","first-page":"9128","DOI":"10.1128\/JVI.01194-15","article-title":"Immunoglobulin with high-titer In vitro cross-neutralizing hepatitis C virus antibodies passively protects chimpanzees from homologous, but not heterologous, challenge","volume":"89","author":"Bukh","year":"2015","journal-title":"J. Virol."},{"key":"10.1016\/j.virusres.2018.02.016_bib0120","doi-asserted-by":"crossref","first-page":"1279","DOI":"10.1053\/j.gastro.2012.02.016","article-title":"Animal models for the study of hepatitis C virus infection and related liver disease","volume":"142","author":"Bukh","year":"2012","journal-title":"Gastroenterology"},{"key":"10.1016\/j.virusres.2018.02.016_bib0125","doi-asserted-by":"crossref","first-page":"S2","DOI":"10.1016\/j.jhep.2016.07.035","article-title":"The history of hepatitis C virus (HCV): Basic research reveals unique features in phylogeny, evolution and the viral life cycle with new perspectives for epidemic control","volume":"65","author":"Bukh","year":"2016","journal-title":"J. Hepatol."},{"key":"10.1016\/j.virusres.2018.02.016_bib0130","doi-asserted-by":"crossref","first-page":"8499","DOI":"10.1073\/pnas.0602957103","article-title":"Inhibition of dsRNA-induced signaling in hepatitis C virus-infected cells by NS3 protease-dependent and -independent mechanisms","volume":"103","author":"Cheng","year":"2006","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.virusres.2018.02.016_bib0135","doi-asserted-by":"crossref","first-page":"1442","DOI":"10.1002\/hep.28571","article-title":"Hepatitis C Disease Burden in the United States in the era of oral direct-acting antivirals","volume":"64","author":"Chhatwal","year":"2016","journal-title":"Hepatology"},{"key":"10.1016\/j.virusres.2018.02.016_bib0140","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1126\/science.2523562","article-title":"Isolation of a cDNA clone derived from a blood-borne non-A, non-B viral hepatitis genome","volume":"244","author":"Choo","year":"1989","journal-title":"Science"},{"key":"10.1016\/j.virusres.2018.02.016_bib0145","doi-asserted-by":"crossref","first-page":"1294","DOI":"10.1073\/pnas.91.4.1294","article-title":"Vaccination of chimpanzees against infection by the hepatitis C virus","volume":"91","author":"Choo","year":"1994","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.virusres.2018.02.016_bib0150","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1056\/NEJMoa1105243","article-title":"Prevention of HIV-1 infection with early antiretroviral therapy","volume":"365","author":"Cohen","year":"2011","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.virusres.2018.02.016_bib0155","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1038\/nature12427","article-title":"Completion of the entire hepatitis C virus life cycle in genetically humanized mice","volume":"501","author":"Dorner","year":"2013","journal-title":"Nature"},{"key":"10.1016\/j.virusres.2018.02.016_bib0160","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1111\/jvh.12533","article-title":"Epidemiology and outcomes of hepatitis C infection in elderly US Veterans","volume":"23","author":"El-Serag","year":"2016","journal-title":"J. Viral Hepat."},{"key":"10.1016\/j.virusres.2018.02.016_bib0165","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1038\/nm1353","article-title":"A T-cell HCV vaccine eliciting effective immunity against heterologous virus challenge in chimpanzees","volume":"12","author":"Folgori","year":"2006","journal-title":"Nat. Med."},{"key":"10.1016\/j.virusres.2018.02.016_bib0170","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1053\/j.gastro.2014.05.010","article-title":"Detection of a sexually transmitted hepatitis C virus protease inhibitor-resistance variant in a human immunodeficiency virus-infected homosexual man","volume":"147","author":"Franco","year":"2014","journal-title":"Gastroenterology"},{"key":"10.1016\/j.virusres.2018.02.016_bib0175","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1038\/ng.3547","article-title":"Whole-genome mutational landscape and characterization of noncoding and structural mutations in liver cancer","volume":"48","author":"Fujimoto","year":"2016","journal-title":"Nat. Genet."},{"key":"10.1016\/j.virusres.2018.02.016_bib0180","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1038\/nature08960","article-title":"Chemical genetics strategy identifies an HCV NS5A inhibitor with a potent clinical effect","volume":"465","author":"Gao","year":"2010","journal-title":"Nature"},{"key":"10.1016\/j.virusres.2018.02.016_bib0185","doi-asserted-by":"crossref","DOI":"10.1016\/j.jhep.2014.07.027","article-title":"Global epidemiology and genotype distribution of the hepatitis C virus infection","volume":"61","author":"Gower","year":"2014","journal-title":"J. Hepatol."},{"key":"10.1016\/j.virusres.2018.02.016_bib0190","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1126\/science.1088774","article-title":"HCV persistence and immune evasion in the absence of memory T cell help","volume":"302","author":"Grakoui","year":"2003","journal-title":"Science"},{"key":"10.1016\/j.virusres.2018.02.016_bib0195","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1038\/nrgastro.2017.106","article-title":"Direct-acting antiviral agents for HCV infection affecting people who inject drugs","volume":"14","author":"Grebely","year":"2017","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"10.1016\/j.virusres.2018.02.016_bib0200","doi-asserted-by":"crossref","first-page":"694","DOI":"10.1038\/ng.2256","article-title":"Integrated analysis of somatic mutations and focal copy-number changes identifies key genes and pathways in hepatocellular carcinoma","volume":"44","author":"Guichard","year":"2012","journal-title":"Nat. Genet."},{"key":"10.1016\/j.virusres.2018.02.016_bib0205","doi-asserted-by":"crossref","first-page":"16247","DOI":"10.1038\/nmicrobiol.2016.247","article-title":"Tuning a cellular lipid kinase activity adapts hepatitis C virus to replication in cell culture","volume":"2","author":"Harak","year":"2016","journal-title":"Nat. Microbiol."},{"key":"10.1016\/j.virusres.2018.02.016_bib0210","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1016\/j.ccr.2009.08.021","article-title":"A lymphotoxin-driven pathway to hepatocellular carcinoma","volume":"16","author":"Haybaeck","year":"2009","journal-title":"Cancer Cell"},{"key":"10.1016\/j.virusres.2018.02.016_bib0215","doi-asserted-by":"crossref","first-page":"S14","DOI":"10.1016\/j.jhep.2014.06.035","article-title":"Innate and adaptive immune responses in HCV infections","volume":"61","author":"Heim","year":"2014","journal-title":"J. Hepatol."},{"key":"10.1016\/j.virusres.2018.02.016_bib0220","doi-asserted-by":"crossref","first-page":"S22","DOI":"10.1016\/j.jhep.2016.07.037","article-title":"Host - hepatitis C viral interactions: the role of genetics","volume":"65","author":"Heim","year":"2016","journal-title":"J. Hepatol."},{"key":"10.1016\/j.virusres.2018.02.016_bib0225","doi-asserted-by":"crossref","first-page":"8101","DOI":"10.1128\/JVI.00127-07","article-title":"The neutralizing activity of anti-hepatitis C virus antibodies is modulated by specific glycans on the E2 envelope protein","volume":"81","author":"Helle","year":"2007","journal-title":"J. Virol."},{"key":"10.1016\/j.virusres.2018.02.016_bib0230","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1080\/14740338.2017.1325869","article-title":"Hepatitis B reactivation during or after direct acting antiviral therapy - implication for susceptible individuals","volume":"16","author":"Holmes","year":"2017","journal-title":"Expert Opin. Drug Saf."},{"key":"10.1016\/j.virusres.2018.02.016_bib0235","doi-asserted-by":"crossref","first-page":"S79","DOI":"10.1016\/j.jhep.2014.07.010","article-title":"Pathogenesis and prevention of hepatitis C virus-induced hepatocellular carcinoma","volume":"61","author":"Hoshida","year":"2014","journal-title":"J. Hepatol."},{"key":"10.1016\/j.virusres.2018.02.016_bib0240","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1111\/j.1600-065X.2010.00977.x","article-title":"Prospects for prophylactic and therapeutic vaccines against the hepatitis C viruses","volume":"239","author":"Houghton","year":"2011","journal-title":"Immunol. Rev."},{"key":"10.1016\/j.virusres.2018.02.016_bib0245","doi-asserted-by":"crossref","first-page":"e1002032","DOI":"10.1371\/journal.pmed.1002032","article-title":"Prices, costs, and affordability of new medicines for hepatitis C in 30 countries: an economic analysis","volume":"13","author":"Iyengar","year":"2016","journal-title":"PLoS Med."},{"key":"10.1016\/j.virusres.2018.02.016_bib0250","doi-asserted-by":"crossref","first-page":"1685","DOI":"10.1056\/NEJMoa1209026","article-title":"Treatment of HCV infection by targeting microRNA","volume":"368","author":"Janssen","year":"2013","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.virusres.2018.02.016_bib0255","first-page":"372","article-title":"Dynamics of IRES-mediated translation","author":"Johnson","year":"2017","journal-title":"Philos. Trans. R. Soc. Lond B Biol. Sci."},{"key":"10.1016\/j.virusres.2018.02.016_bib0260","doi-asserted-by":"crossref","first-page":"1577","DOI":"10.1126\/science.1113329","article-title":"Modulation of hepatitis C virus RNA abundance by a liver-specific MicroRNA","volume":"309","author":"Jopling","year":"2005","journal-title":"Science"},{"key":"10.1016\/j.virusres.2018.02.016_bib0265","doi-asserted-by":"crossref","first-page":"996","DOI":"10.1053\/j.gastro.2017.06.012","article-title":"Risk of hepatocellular cancer in HCV patients treated with direct-acting antiviral agents","volume":"153","author":"Kanwal","year":"2017","journal-title":"Gastroenterology"},{"key":"10.1016\/j.virusres.2018.02.016_bib0270","doi-asserted-by":"crossref","first-page":"6149","DOI":"10.1128\/JVI.00248-09","article-title":"Mutations in hepatitis C virus E2 located outside the CD81 binding sites lead to escape from broadly neutralizing antibodies but compromise virus infectivity","volume":"83","author":"Keck","year":"2009","journal-title":"J. Virol."},{"key":"10.1016\/j.virusres.2018.02.016_bib0275","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1038\/nature13117","article-title":"Structure of the core ectodomain of the hepatitis C virus envelope glycoprotein 2","volume":"509","author":"Khan","year":"2014","journal-title":"Nature"},{"key":"10.1016\/j.virusres.2018.02.016_bib0280","doi-asserted-by":"crossref","first-page":"12276","DOI":"10.1128\/JVI.00970-14","article-title":"Modulation of hepatitis C virus genome replication by glycosphingolipids and four-phosphate adaptor protein 2","volume":"88","author":"Khan","year":"2014","journal-title":"J. Virol. JVI"},{"key":"10.1016\/j.virusres.2018.02.016_bib0285","doi-asserted-by":"crossref","first-page":"1090","DOI":"10.1126\/science.1243876","article-title":"Hepatitis C virus E2 envelope glycoprotein core structure","volume":"342","author":"Kong","year":"2013","journal-title":"Science"},{"key":"10.1016\/j.virusres.2018.02.016_bib0290","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1038\/ng.809","article-title":"Genome-wide association study identifies a susceptibility locus for HCV-induced hepatocellular carcinoma","volume":"43","author":"Kumar","year":"2011","journal-title":"Nat. Genet."},{"key":"10.1016\/j.virusres.2018.02.016_bib0295","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1126\/science.2496467","article-title":"An assay for circulating antibodies to a major etiologic virus of human non-A, non-B hepatitis","volume":"244","author":"Kuo","year":"1989","journal-title":"Science"},{"key":"10.1016\/j.virusres.2018.02.016_bib0300","doi-asserted-by":"crossref","first-page":"1575","DOI":"10.1128\/JVI.78.3.1575-1581.2004","article-title":"Cross-genotype immunity to hepatitis C virus","volume":"78","author":"Lanford","year":"2004","journal-title":"J. Virol."},{"key":"10.1016\/j.virusres.2018.02.016_bib0305","doi-asserted-by":"crossref","first-page":"e59776","DOI":"10.1371\/journal.pone.0059776","article-title":"A hepatitis C virus (HCV) vaccine comprising envelope glycoproteins gpE1\/gpE2 derived from a single isolate elicits broad cross-genotype neutralizing antibodies in humans","volume":"8","author":"Law","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.virusres.2018.02.016_bib0310","series-title":"Global Policy Report on the Prevention and Control of Viral Hepatitis in WHO Member States. WHO Library Cataloguing-in-Publication Data Prevention and Control of Viral Hepatitis in WHO Member States","author":"Lazarus","year":"2013"},{"key":"10.1016\/j.virusres.2018.02.016_bib0315","doi-asserted-by":"crossref","first-page":"4991","DOI":"10.1073\/pnas.1016606108","article-title":"MicroRNA-122 antagonism against hepatitis C virus genotypes 1-6 and reduced efficacy by host RNA insertion or mutations in the HCV 5' UTR","volume":"108","author":"Li","year":"2011","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.virusres.2018.02.016_bib0320","article-title":"Naturally occurring resistance-associated variants to hepatitis C virus direct-acting antiviral agents in treatment-naive HCV genotype 6a-infected patients","author":"Li","year":"2017","journal-title":"Biomed. Res. Int."},{"key":"10.1016\/j.virusres.2018.02.016_bib0325","doi-asserted-by":"crossref","first-page":"688","DOI":"10.1038\/nrmicro3098","article-title":"The ins and outs of hepatitis C virus entry and assembly","volume":"11","author":"Lindenbach","year":"2013","journal-title":"Nat. Rev. Microbiol."},{"key":"10.1016\/j.virusres.2018.02.016_bib0330","doi-asserted-by":"crossref","first-page":"10149","DOI":"10.1073\/pnas.0403519101","article-title":"Neutralizing antibody response during acute and chronic hepatitis C virus infection","volume":"101","author":"Logvinoff","year":"2004","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.virusres.2018.02.016_bib0335","doi-asserted-by":"crossref","first-page":"6001","DOI":"10.1073\/pnas.0601523103","article-title":"Viral and therapeutic control of IFN-beta promoter stimulator 1 during hepatitis C virus infection","volume":"103","author":"Loo","year":"2006","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.virusres.2018.02.016_bib0340","doi-asserted-by":"crossref","first-page":"1099","DOI":"10.1016\/j.cell.2015.02.025","article-title":"Hepatitis C virus RNA functionally sequesters miR-122","volume":"160","author":"Luna","year":"2015","journal-title":"Cell"},{"key":"10.1016\/j.virusres.2018.02.016_bib0345","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1038\/nbt.3179","article-title":"Clearance of persistent hepatitis C virus infection in humanized mice using a claudin-1-targeting monoclonal antibody","volume":"33","author":"Mailly","year":"2015","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.virusres.2018.02.016_bib0350","doi-asserted-by":"crossref","first-page":"6586","DOI":"10.1128\/JVI.76.13.6586-6595.2002","article-title":"Previously infected and recovered chimpanzees exhibit rapid responses that control hepatitis C virus replication upon rechallenge","volume":"76","author":"Major","year":"2002","journal-title":"J. Virol."},{"key":"10.1016\/j.virusres.2018.02.016_bib0355","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1016\/j.jhep.2014.05.043","article-title":"Restoration of HCV-specific CD8+ T cell function by interferon-free therapy","volume":"61","author":"Martin","year":"2014","journal-title":"J. Hepatol."},{"key":"10.1016\/j.virusres.2018.02.016_bib0360","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/j.chom.2014.12.014","article-title":"miR-122 stimulates hepatitis C virus RNA synthesis by altering the balance of viral RNAs engaged in replication versus translation","volume":"17","author":"Masaki","year":"2015","journal-title":"Cell Host. Microbe"},{"key":"10.1016\/j.virusres.2018.02.016_bib0365","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1053\/j.gastro.2014.04.021","article-title":"Kinetic analyses reveal potent and early blockade of hepatitis C virus assembly by NS5A inhibitors","volume":"147","author":"McGivern","year":"2014","journal-title":"Gastroenterology"},{"key":"10.1016\/j.virusres.2018.02.016_bib0370","doi-asserted-by":"crossref","first-page":"1478","DOI":"10.1016\/S0140-6736(02)08435-0","article-title":"Protection against persistence of hepatitis C","volume":"359","author":"Mehta","year":"2002","journal-title":"Lancet"},{"key":"10.1016\/j.virusres.2018.02.016_bib0375","doi-asserted-by":"crossref","first-page":"3352","DOI":"10.1172\/JCI75938","article-title":"Endogenous intrahepatic IFNs and association with IFN-free HCV treatment outcome","volume":"124","author":"Meissner","year":"2014","journal-title":"J. Clin. Invest"},{"key":"10.1016\/j.virusres.2018.02.016_bib0380","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1002\/hep.24171","article-title":"In vivo evaluation of the cross-genotype neutralizing activity of polyclonal antibodies against hepatitis C virus","volume":"53","author":"Meuleman","year":"2011","journal-title":"Hepatology"},{"key":"10.1016\/j.virusres.2018.02.016_bib0385","doi-asserted-by":"crossref","first-page":"1186","DOI":"10.1093\/infdis\/jir511","article-title":"Vaccine-induced cross-genotype reactive neutralizing antibodies against hepatitis C virus","volume":"204","author":"Meunier","year":"2011","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.virusres.2018.02.016_bib0390","doi-asserted-by":"crossref","first-page":"1167","DOI":"10.1038\/nature04193","article-title":"Cardif is an adaptor protein in the RIG-I antiviral pathway and is targeted by hepatitis C virus","volume":"437","author":"Meylan","year":"2005","journal-title":"Nature"},{"key":"10.1016\/j.virusres.2018.02.016_bib0395","doi-asserted-by":"crossref","DOI":"10.1016\/j.jhep.2016.07.012","article-title":"HCV epidemiology in high-risk groups and the risk of reinfection","volume":"65","author":"Midgard","year":"2016","journal-title":"J. Hepatol."},{"key":"10.1016\/j.virusres.2018.02.016_bib0400","doi-asserted-by":"crossref","first-page":"e1002895","DOI":"10.1371\/journal.ppat.1002895","article-title":"Human monoclonal antibody HCV1 effectively prevents and treats HCV infection in chimpanzees","volume":"8","author":"Morin","year":"2012","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.virusres.2018.02.016_bib0405","doi-asserted-by":"crossref","first-page":"1927","DOI":"10.1053\/j.gastro.2008.02.033","article-title":"Functional restoration of HCV-specific CD8 T cells by PD-1 blockade is defined by PD-1 expression and compartmentalization","volume":"134","author":"Nakamoto","year":"2008","journal-title":"Gastroenterology"},{"key":"10.1016\/j.virusres.2018.02.016_bib0410","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.immuni.2013.12.010","article-title":"Immune responses to HCV and other hepatitis viruses","volume":"40","author":"Park","year":"2014","journal-title":"Immunity"},{"key":"10.1016\/j.virusres.2018.02.016_bib0415","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1016\/j.chom.2014.10.008","article-title":"Hepatitis C virus RNA replication and assembly: living on the fat of the land","volume":"16","author":"Paul","year":"2014","journal-title":"Cell Host. Microbe"},{"key":"10.1016\/j.virusres.2018.02.016_bib0420","doi-asserted-by":"crossref","first-page":"S87","DOI":"10.1016\/j.jhep.2015.02.006","article-title":"From non-A, non-B hepatitis to hepatitis C virus cure","volume":"62","author":"Pawlotsky","year":"2015","journal-title":"J. Hepatol."},{"key":"10.1016\/j.virusres.2018.02.016_bib0425","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1053\/j.gastro.2016.04.003","article-title":"Hepatitis C virus resistance to direct-acting antiviral drugs in interferon-free regimens","volume":"151","author":"Pawlotsky","year":"2016","journal-title":"Gastroenterology"},{"key":"10.1016\/j.virusres.2018.02.016_bib0430","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1002\/hep.29185","article-title":"Hepatitis B virus reactivation during direct-acting antiviral treatment of chronic hepatitis C: A hidden danger of an otherwise major success story","volume":"66","author":"Perrillo","year":"2017","journal-title":"Hepatology"},{"key":"10.1016\/j.virusres.2018.02.016_bib0435","doi-asserted-by":"crossref","first-page":"6025","DOI":"10.1073\/pnas.0607026104","article-title":"Rapid induction of virus-neutralizing antibodies and viral clearance in a single-source outbreak of hepatitis C","volume":"104","author":"Pestka","year":"2007","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.virusres.2018.02.016_bib0440","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1016\/j.jinf.2015.07.006","article-title":"Hepatitis C virus reinfection after sustained virological response in HIV-infected patients with chronic hepatitis C","volume":"71","author":"Pineda","year":"2015","journal-title":"J. Infect."},{"key":"10.1016\/j.virusres.2018.02.016_bib0445","doi-asserted-by":"crossref","first-page":"1881","DOI":"10.1002\/hep.28705","article-title":"Hypervariable region 1 shielding of hepatitis C virus is a main contributor to genotypic differences in neutralization sensitivity","volume":"64","author":"Prentoe","year":"2016","journal-title":"Hepatology"},{"key":"10.1016\/j.virusres.2018.02.016_bib0450","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1053\/j.gastro.2016.07.013","article-title":"Robust HCV genotype 3a infectious cell culture system permits identification of escape variants with resistance to sofosbuvir","volume":"151","author":"Ramirez","year":"2016","journal-title":"Gastroenterology"},{"key":"10.1016\/j.virusres.2018.02.016_bib0455","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/j.chom.2010.12.002","article-title":"Recruitment and activation of a lipid kinase by hepatitis C virus NS5A is essential for integrity of the membranous replication compartment","volume":"9","author":"Reiss","year":"2011","journal-title":"Cell Host. Microbe"},{"key":"10.1016\/j.virusres.2018.02.016_bib0460","doi-asserted-by":"crossref","first-page":"1312","DOI":"10.1002\/cncr.29936","article-title":"Annual Report to the Nation on the Status of Cancer, 1975-2012, featuring the increasing incidence of liver cancer","volume":"122","author":"Ryerson","year":"2016","journal-title":"Cancer"},{"key":"10.1016\/j.virusres.2018.02.016_bib0465","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1038\/nature14899","article-title":"SEC14L2 enables pan-genotype HCV replication in cell culture","volume":"524","author":"Saeed","year":"2015","journal-title":"Nature"},{"key":"10.1016\/j.virusres.2018.02.016_bib0470","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1146\/annurev-virology-110615-042409","article-title":"Unraveling the mysterious interactions between hepatitis C virus RNA and liver-specific microRNA-122","volume":"3","author":"Sarnow","year":"2016","journal-title":"Annu. Rev. Virol."},{"key":"10.1016\/j.virusres.2018.02.016_bib0475","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1016\/j.jhep.2015.09.011","article-title":"The importance of resistance to direct antiviral drugs in HCV infection in clinical practice","volume":"64","author":"Sarrazin","year":"2016","journal-title":"J. Hepatol."},{"key":"10.1016\/j.virusres.2018.02.016_bib0480","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1038\/nm.3248","article-title":"Understanding the hepatitis C virus life cycle paves the way for highly effective therapies","volume":"19","author":"Scheel","year":"2013","journal-title":"Nat. Med."},{"key":"10.1016\/j.virusres.2018.02.016_bib0485","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.antiviral.2014.12.014","article-title":"Surveying the global virome: identification and characterization of HCV-related animal hepaciviruses","volume":"115","author":"Scheel","year":"2015","journal-title":"Antiviral Res."},{"key":"10.1016\/j.virusres.2018.02.016_bib0490","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1016\/j.chom.2016.02.007","article-title":"A broad RNA virus survey reveals both miRNA dependence and functional sequestration","volume":"19","author":"Scheel","year":"2016","journal-title":"Cell Host Microbe"},{"key":"10.1016\/j.virusres.2018.02.016_bib0495","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1038\/ng.3252","article-title":"Exome sequencing of hepatocellular carcinomas identifies new mutational signatures and potential therapeutic targets","volume":"47","author":"Schulze","year":"2015","journal-title":"Nat. Genet."},{"key":"10.1016\/j.virusres.2018.02.016_bib0500","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1053\/j.gastro.2015.03.004","article-title":"Successful interferon-Free therapy of chronic hepatitis C virus infection normalizes natural killer cell function","volume":"149","author":"Serti","year":"2015","journal-title":"Gastroenterology"},{"key":"10.1016\/j.virusres.2018.02.016_bib0505","doi-asserted-by":"crossref","first-page":"1645","DOI":"10.1084\/jem.20030239","article-title":"Memory CD8+ T cells are required for protection from persistent hepatitis C virus infection","volume":"197","author":"Shoukry","year":"2003","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.virusres.2018.02.016_bib0510","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1099\/jgv.0.000672","article-title":"ICTV virus taxonomy profile: flaviviridae","volume":"98","author":"Simmonds","year":"2017","journal-title":"J. Gen. Virol."},{"key":"10.1016\/j.virusres.2018.02.016_bib0515","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1093\/cid\/civ948","article-title":"Risk of late relapse or reinfection with hepatitis C virus after achieving a sustained virological response: a systematic review and meta-analysis","volume":"62","author":"Simmons","year":"2016","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.virusres.2018.02.016_bib0520","doi-asserted-by":"crossref","DOI":"10.1002\/hep.29837","article-title":"Resistance analysis of genotype 3 HCV indicates subtypes inherently resistant to NS5A inhibitors","author":"Smith","year":"2018","journal-title":"Hepatology"},{"key":"10.1016\/j.virusres.2018.02.016_bib0525","doi-asserted-by":"crossref","DOI":"10.1128\/JVI.01196-17","article-title":"Hepatitis C virus replication depends on endosomal cholesterol homeostasis","author":"Stoeck","year":"2017","journal-title":"J. Virol. JVI"},{"key":"10.1016\/j.virusres.2018.02.016_bib0530","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1016\/S1473-3099(08)70126-9","article-title":"Hepatitis C vaccine: supply and demand","volume":"8","author":"Strickland","year":"2008","journal-title":"Lancet Infect. Dis."},{"key":"10.1016\/j.virusres.2018.02.016_bib0535","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.tem.2009.07.005","article-title":"Hepatitis C virus hijacks host lipid metabolism","volume":"21","author":"Syed","year":"2010","journal-title":"Trends Endocrinol. Metab"},{"key":"10.1016\/j.virusres.2018.02.016_bib0540","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1111\/j.1574-6976.2011.00319.x","article-title":"Failure of innate and adaptive immune responses in controlling hepatitis C virus infection","volume":"36","author":"Thimme","year":"2012","journal-title":"FEMS Microbiol. Rev."},{"key":"10.1016\/j.virusres.2018.02.016_bib0545","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1002\/hep.21959","article-title":"Hepatitis C virus cell-cell transmission in hepatoma cells in the presence of neutralizing antibodies","volume":"47","author":"Timpe","year":"2008","journal-title":"Hepatology"},{"key":"10.1016\/j.virusres.2018.02.016_bib0550","doi-asserted-by":"crossref","DOI":"10.1002\/hep.29494","article-title":"Viral persistence, liver disease and host response in Hepatitis C-like virus rat model","author":"Trivedi","year":"2017","journal-title":"Hepatology"},{"key":"10.1016\/j.virusres.2018.02.016_bib0555","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1515\/hsz-2017-0118","article-title":"Chronic viral hepatitis and its association with liver cancer","volume":"398","author":"Tu","year":"2017","journal-title":"Biol. Chem."},{"key":"10.1016\/j.virusres.2018.02.016_bib0560","unstructured":"UN AIDS. 2016. http:\/\/www.unaids.org\/en\/resources\/fact-sheet. 2016."},{"key":"10.1016\/j.virusres.2018.02.016_bib0565","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1186\/s12977-018-0395-4","article-title":"HIV evolution and diversity in ART-treated patients","volume":"15","author":"van Zyl","year":"2018","journal-title":"Retrovirology"},{"key":"10.1016\/j.virusres.2018.02.016_bib0570","doi-asserted-by":"crossref","first-page":"2584","DOI":"10.1001\/jama.2012.144878","article-title":"Association between sustained virological response and all-cause mortality among patients with chronic hepatitis C and advanced hepatic fibrosis","volume":"308","author":"van der Meer","year":"2012","journal-title":"JAMA"},{"key":"10.1016\/j.virusres.2018.02.016_bib0575","doi-asserted-by":"crossref","first-page":"e1006214","DOI":"10.1371\/journal.ppat.1006214","article-title":"Applying antibody-sensitive hypervariable region 1-deleted hepatitis C virus to the study of escape pathways of neutralizing human monoclonal antibody AR5A","volume":"13","author":"Velazquez-Moctezuma","year":"2017","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.virusres.2018.02.016_bib0580","doi-asserted-by":"crossref","first-page":"1117","DOI":"10.1002\/hep.28989","article-title":"The core domain of hepatitis C virus glycoprotein E2 generates potent cross-neutralizing antibodies in guinea pigs","volume":"65","author":"Vietheer","year":"2017","journal-title":"Hepatology"},{"key":"10.1016\/j.virusres.2018.02.016_bib0585","unstructured":"WHO global hepatitis 2017 report. 2017. <tp:e-path> http:\/\/www.who.int\/mediacentre\/factsheets\/fs164\/en.<\/doc_ref<\/tp:e-path>."},{"key":"10.1016\/j.virusres.2018.02.016_bib0590","doi-asserted-by":"crossref","first-page":"1373","DOI":"10.1053\/j.gastro.2014.02.002","article-title":"Oxysterol-binding protein is a phosphatidylinositol 4-kinase effector required for HCV replication membrane integrity and cholesterol trafficking","volume":"146","author":"Wang","year":"2014","journal-title":"Gastroenterology"},{"key":"10.1016\/j.virusres.2018.02.016_bib0595","doi-asserted-by":"crossref","first-page":"7142","DOI":"10.1128\/JVI.75.15.7142-7148.2001","article-title":"Intrahepatic genetic inoculation of hepatitis C virus RNA confers cross-protective immunity","volume":"75","author":"Weiner","year":"2001","journal-title":"J. Virol."},{"key":"10.1016\/j.virusres.2018.02.016_bib0600","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1038\/nri3862","article-title":"Molecular and cellular insights into T cell exhaustion","volume":"15","author":"Wherry","year":"2015","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.virusres.2018.02.016_bib0605","doi-asserted-by":"crossref","first-page":"15050","DOI":"10.1038\/ncomms15050","article-title":"TCF1(+) hepatitis C virus-specific CD8(+) T cells are maintained after cessation of chronic antigen stimulation","volume":"8","author":"Wieland","year":"2017","journal-title":"Nat. Commun."},{"key":"10.1016\/j.virusres.2018.02.016_bib0610","doi-asserted-by":"crossref","first-page":"1987","DOI":"10.1002\/1873-3468.12157","article-title":"In vivo models of hepatitis B and C virus infection","volume":"590","author":"Winer","year":"2016","journal-title":"FEBS Lett."},{"key":"10.1016\/j.virusres.2018.02.016_bib0615","doi-asserted-by":"crossref","first-page":"14278","DOI":"10.1128\/JVI.01911-14","article-title":"Recombinant hepatitis C virus envelope glycoprotein vaccine elicits antibodies targeting multiple epitopes on the envelope glycoproteins associated with broad cross-neutralization","volume":"88","author":"Wong","year":"2014","journal-title":"J. Virol. JVI"},{"key":"10.1016\/j.virusres.2018.02.016_bib0620","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1038\/nm.3610","article-title":"Regulation of the hepatitis C virus RNA replicase by endogenous lipid peroxidation","volume":"20","author":"Yamane","year":"2014","journal-title":"Nat. Med."},{"key":"10.1016\/j.virusres.2018.02.016_bib0625","doi-asserted-by":"crossref","first-page":"e00049","DOI":"10.7554\/eLife.00049","article-title":"Sodium taurocholate cotransporting polypeptide is a functional receptor for human hepatitis B and D virus","volume":"1","author":"Yan","year":"2012","journal-title":"Elife"},{"key":"10.1016\/j.virusres.2018.02.016_bib0630","first-page":"87","article-title":"Hepatitis C virus entry","volume":"369","author":"Zeisel","year":"2013","journal-title":"Curr. Top. Microbiol. Immunol."},{"key":"10.1016\/j.virusres.2018.02.016_bib0635","doi-asserted-by":"crossref","first-page":"5659","DOI":"10.3390\/v7112898","article-title":"Host-targeting agents to prevent and cure hepatitis C virus infection","volume":"7","author":"Zeisel","year":"2015","journal-title":"Viruses"}],"container-title":["Virus Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168170218300054?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168170218300054?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,10,12]],"date-time":"2019-10-12T01:04:29Z","timestamp":1570842269000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0168170218300054"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,3]]},"references-count":127,"alternative-id":["S0168170218300054"],"URL":"https:\/\/doi.org\/10.1016\/j.virusres.2018.02.016","relation":{},"ISSN":["0168-1702"],"issn-type":[{"value":"0168-1702","type":"print"}],"subject":[],"published":{"date-parts":[[2018,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Critical challenges and emerging opportunities in hepatitis C virus research in an era of potent antiviral therapy: Considerations for scientists and funding agencies","name":"articletitle","label":"Article Title"},{"value":"Virus Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.virusres.2018.02.016","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}]}}